A marker of homologous recombination predicts pathologic complete response to neoadjuvant chemotherapy in primary breast cancer, by Graeser M, McCarthy A, Lord CJ, et al: Clin Cancer Res 16:6159-6168, 2010 Journal Article

  


Authors: Mutter, R. W.; Powell, S. N.
Article Title: A marker of homologous recombination predicts pathologic complete response to neoadjuvant chemotherapy in primary breast cancer, by Graeser M, McCarthy A, Lord CJ, et al: Clin Cancer Res 16:6159-6168, 2010
Keywords: signal transduction; human tissue; treatment response; primary tumor; major clinical study; histopathology; note; antineoplastic agent; ki 67 antigen; cell proliferation; dna damage; homologous recombination; dna repair; breast cancer; epidermal growth factor receptor 2; immunofluorescence; brca1 protein; brca2 protein; adjuvant chemotherapy; scoring system; ionizing radiation; estrogen receptor; anthracycline; histone h2ax; rad51 protein; triple negative breast cancer; prognosis; human; geminin
Journal Title: Breast Diseases: A Year Book Quarterly
Volume: 22
Issue: 3
ISSN: 1043-321X
Publisher: Elsevier Inc.  
Date Published: 2011-01-01
Start Page: 316
End Page: 318
Language: English
DOI: 10.1016/j.breastdis.2011.06.011
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-80052062206&doi=10.1016%2fj.breastdis.2011.06.011&partnerID=40&md5=9cf0f2e8b76414a77f4f3c059762143d
Notes: Note -- Export Date: 14 August 2017 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Simon Nicholas Powell
    331 Powell
  2. Robert Wesley Mutter
    17 Mutter
Related MSK Work